Literature DB >> 8259418

MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas.

H D Sostman1, D M Prescott, M W Dewhirst, R K Dodge, D E Thrall, R L Page, J A Tucker, J M Harrelson, G Reece, K A Leopold.   

Abstract

PURPOSE: To enable prediction of tumor response to a particular treatment.
MATERIALS AND METHODS: The authors studied the value of hydrogen-1 T2 and phosphorus-31 magnetic resonance (MR) spectroscopic metabolic determinations as indicators of prognosis in 20 humans and 10 dogs with soft-tissue sarcomas. All patients underwent combined fractionated radiation therapy and hyperthermia. Surgical resection of the entire tumor in humans allowed comparison of pretherapy T2 and MR spectroscopic parameters with subsequent histologic findings. Long-term clinical follow-up (no surgical intervention) was available with the dogs and allowed comparison of pretherapy pH with the duration of local relapse-free survival.
RESULTS: A relationship exists between pretherapy pH and T2 and ultimate tumor necrosis in humans and pretherapy pH and time elapsed until local failure in dogs.
CONCLUSION: MR imaging and spectroscopy could be useful in the prognosis of patients with soft-tissue sarcomas before therapy is initiated.

Entities:  

Mesh:

Year:  1994        PMID: 8259418     DOI: 10.1148/radiology.190.1.8259418

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Imaging of soft-tissue sarcomas.

Authors:  D G Varma
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 2.  Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.

Authors:  Ty K Subhawong; Xin Wang; Daniel J Durand; Michael A Jacobs; John A Carrino; Antonio J Machado; Laura M Fayad
Journal:  AJR Am J Roentgenol       Date:  2012-01       Impact factor: 3.959

Review 3.  Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.

Authors:  Xin Wang; Michael A Jacobs; Laura Fayad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

Review 4.  Monitoring tumour response.

Authors:  J E Husband
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 5.  Manipulating extracellular tumour pH: an effective target for cancer therapy.

Authors:  Guanyu Hao; Zhi Ping Xu; Li Li
Journal:  RSC Adv       Date:  2018-06-19       Impact factor: 4.036

6.  Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo.

Authors:  M Zhao; J G Pipe; J Bonnett; J L Evelhoch
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

7.  Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility.

Authors:  Tedros Bezabeh; Samy El-Sayed; Rakesh Patel; Ray L Somorjai; Vivien Bramwell; Rita Kandel; Ian C P Smith
Journal:  Sarcoma       Date:  2002
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.